Top 50 Biotechnology Startup Investors in Japan (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mitsubishi UFJ Capital
VC Fund
|
20 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $952k–$269M |
|
UntroD Capital
VC Fund
|
19 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Health Care | $772k–$241M |
|
ANRI
VC Fund
|
18 | Japan, United States, India | Seed, Series A | Software, Health Care, Information Technology | $497k–$78M |
|
SMBC Venture Capital
VC Fund
|
18 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $2.3M–$269M |
|
Osaka University Venture Capital
VC Fund
|
16 | Japan | Seed, Series A | Biotechnology, Health Care, Manufacturing | $3M–$142M |
|
Fast Track Initiative, Inc.
VC Fund
|
16 | Japan, United States, United Kingdom | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $1.2M–$184M |
|
JAFCO
VC Fund
|
12 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $1.9M–$198M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
12 | Japan, United States, India | Seed, Series A | Health Care, Biotechnology, Medical | $3.1M–$78M |
|
Keio Innovation Initiative
VC Fund
|
12 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $1.5M–$64M |
|
Mizuho Capital
VC Fund
|
10 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Internet | $1.5M–$340M |
|
SBI Investment
VC Fund
|
10 | Japan, South Korea, United States | Series B, Series A | Software, Information Technology, Financial Services | $2M–$227M |
|
DBJ Capital
VC Fund
|
9 | Japan, United States, Australia | Series A, Series B | Software, Health Care, Biotechnology | $2.7M–$354M |
|
Real Tech Japan
VC Fund
|
9 | Japan, Singapore, Austria | Series A, Seed | Manufacturing, Biotechnology, Medical | $1.2M–$241M |
|
Japan Science and Technology Agency
VC Fund
|
8 | Japan | Series A, Seed | Medical, Biotechnology, Manufacturing | $1.7M–$255M |
|
Miyako Capital
VC Fund
|
8 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $750k–$354M |
|
DG Daiwa Ventures
VC Fund
|
7 | Japan, United States, India | Seed, Series A, Series B | Software, FinTech, Internet | $679k–$122M |
|
Nippon Venture Capital
VC Fund
|
7 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Information Technology | $1.5M–$269M |
|
Nissay Capital
VC Fund
|
7 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $610k–$71M |
|
Miraidoa
VC Fund
|
7 | Japan, United States, Myanmar | Seed, Series A | Health Care, Manufacturing, Information Technology | $933k–$58M |
|
FFG Venture Business Partners
VC Fund
|
5 | Japan, Indonesia, United States | Series A, Seed | Software, Health Care, Artificial Intelligence | $1M–$50M |
|
Senshu Ikeda Capital
VC Fund
|
5 | Japan | Series A, Seed | Software, Manufacturing, Internet | $1M–$92M |
|
Fujifilm
VC Fund
|
4 | Japan, United States, China | Series A, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
Incubate Fund
VC Fund
|
4 | Japan, United States, India | Seed, Series A | Software, Information Technology, E-Commerce | $314k–$91M |
|
Delight Ventures
VC Fund
|
4 | Japan, United States, South Korea | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $429k–$312M |
|
JIC Venture Growth Investments
VC Fund
|
4 | Japan, Singapore, United States | Series B, Series C | Information Technology, Software, Medical | $4.1M–$354M |
|
Remiges Ventures
VC Fund
|
4 | United States, Japan, Canada | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $6.6M–$553M |
|
Angel Bridge
VC Fund
|
4 | Japan | Series A, Seed, Series B | Information Technology, Software, Consulting | $792k–$62M |
|
F-Prime
VC Fund
|
4 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $9.2M–$165M |
|
D3
VC Fund
|
4 | Japan, United States | Series A, Seed, Series B | Medical, Software, Therapeutics | $690k–$51M |
|
Takeda
VC Fund
|
3 | United States, Japan, China | Grant, Corporate Round | Biotechnology, Health Care, Pharmaceutical | $5k–$1.4B |
|
KSP
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Health Care, Medical | |
|
SPARX Group
VC Fund
|
3 | Japan, United States, United Kingdom | Series B, Series A | Software, Artificial Intelligence, Information Technology | $11M–$425M |
|
Daiwa Corporate Investment
VC Fund
|
3 | Japan, United States, France | Series A, Seed | Software, Task Management, Internet | $4.3M–$71M |
|
IT-Farm
VC Fund
|
3 | United States, Japan, Germany | Seed, Series A | Software, Health Care, Medical | $1.8M–$20M |
|
Green Core
VC Fund
|
3 | Japan | Series A, Seed | Pharmaceutical, Health Care, Medical | $2M–$4.8M |
|
Darwin Venture Management
VC Fund
|
3 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $1M–$76M |
|
Chushin Venture Capital
VC Fund
|
3 | Japan | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $955k–$128M |
|
Antler
VC Fund
|
3 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $108k–$28M |
|
WASEDA University Ventures
VC Fund
|
3 | Japan, United States, United Kingdom | Seed, Series A, Convertible Note | Medical, Biotechnology, Information Technology | $1.2M–$38M |
|
Takeda Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Capital Medica Ventures
VC Fund
|
3 | Japan | Seed, Series A | Medical, Health Care, Software | $403k–$50M |
|
Kyogin Lease & Capital
VC Fund
|
3 | Japan | Series A, Seed | Manufacturing, Task Management, Medical | $515k–$61M |
|
Higin Capital
VC Fund
|
3 | Japan | Series A, Series B | Medical, Biotechnology, Software | $1.2M–$75M |
|
Sosei CVC
VC Fund
|
3 | Japan | Series A, Series B | Biotechnology, Medical, Pharmaceutical | |
|
Tsukuba Institute of Research
VC Fund
|
3 | Japan | Series A, Seed | Medical, Biotechnology, Manufacturing | $3M–$106M |
|
Eight Roads Ventures
VC Fund
|
3 | United States, China, India | Series B, Series A, Series C | Software, Health Care, Biotechnology | $6.4M–$115M |
|
QB Capital
VC Fund
|
3 | Japan, Singapore, United States | Seed, Series A | Manufacturing, Medical, Biotechnology | $641k–$213M |
|
Energy & Environment Investment
VC Fund
|
3 | Japan, United States, Canada | Series A, Series B | Energy, Internet of Things, Software | $2M–$553M |
|
Chugin Capital Partner
VC Fund
|
3 | Japan | Series A, Seed, Series B | Manufacturing, Software, Information Technology | $760k–$54M |
|
Koki Yabu
Angel
|
2 | Japan | Angel, Pre-Seed | Content, Finance, Data Mining | |
| Access all 501 investors in Japan Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 552
- Round size: Series A $952k–$86M; Series B $4.2M–$269M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 130
- Round size: Seed $772k–$43M; Series A $2.1M–$241M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- Formas.AI — Formas.AI is a multi-modal, AI-powered design platform specifically built for architects, designers, and educators to generate and visualize creative architectural concepts.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 260
- Round size: Seed $497k–$41M; Series A $2.4M–$78M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- Tacoms — CAMEL is a service that allows you to easily manage orders from multiple food delivery / takeout services on a single tablet.
- Any Style —
- Smile Robotics — Smile Robotics provides Service Robots in Japan.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 553
- Round size: Series A $2.3M–$128M; Series B $3.2M–$269M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Atom — Atom is a humanoid robot built platform. Its bipedal, dual-armed robots are designed not just as industrial tools but as collaborators that expand human capability. By combining advanced Physical AI—environmental perception, judgment, and action planning—with robust robotic hardware, Atom is creating adaptive agents capable of working acrossdiverse settings to augment or, where appropriate, replace human labor. The company positions these robots as a next step in societal evolution: a new class of machines that learn and behave in human-like ways to advance productivity, safety, and quality of life.
- Link Therapeutics — Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 83
- Round size: Seed $4.5M–$50M; Series A $3M–$142M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- LQUOM — QWAVE offers cryptography communication technology.
- Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $1.2M–$117M; Series A $1.5M–$113M; Series B $7.7M–$184M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2021
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 295
- Round size: Series A $1.9M–$170M; Series B $7M–$198M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- CaTe —
- EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
- Yokohama Vanilla — Yokohama Vanilla is a Company which operates Yokohama-based gift sweets brand.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 182
- Round size: Seed $3.1M–$48M; Series A $3.6M–$78M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- TXP Medical — TXP Medical build a next-generation medical system through acute care.
- Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 87
- Round size: Seed $1.5M–$57M; Series A $2.3M–$64M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Grafenary — Graphenary creates unique graphene optical devices using graphene materials with a variety of remarkable features.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 460
- Round size: Series A $1.5M–$115M; Series B $2.4M–$340M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- CaTe —
- FunPep — FunPep is an Industry-university collaboration bioventure company.
- NEXT NEW WORLD — NEXT NEW WORLD develops and manufactures natural products with low impact on the environment. It uses sustainable Japanese silk to manufacture apparel and cosmetic products.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 375
- Round size: Series A $2M–$156M; Series B $4.9M–$227M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Direava —
- Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 156
- Round size: Series A $2.7M–$113M; Series B $6.9M–$354M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Ginco — Ginco's goal is to Change the relationship between individuals and assets by making full use of block chain technology. The primary focus of Ginco, its cryptocurrency wallet app, is centered around dApp and the On-Chain function, and the company plans to expand its business in a multifaceted manner while watching trends in the ecosystemdevelopment. In the future, they were told that they have the possibility of developing with DEXs (decentralized exchanges).
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- Arrowsmith — Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Series A, Seed
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $1.2M–$43M; Series A $6M–$241M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 54
- Round size: Seed $1.7M–$50M; Series A $2.3M–$255M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $750k–$43M; Series A $6.1M–$75M; Series B $3.7M–$354M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: Software, FinTech, Internet
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 81
- Round size: Seed $679k–$8M; Series A $1.1M–$103M; Series B $6.5M–$122M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Imiron — Imiron the process and tools used for modeling mathematical behavior in order to comprehend its fundamentals.
- Dioseve — Dioseve is providing novel possibilities for all life.
- CULTA —
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 169
- Round size: Series A $1.5M–$74M; Series B $3.3M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
- Space BD — Space BD aims to become a one-stop shop to respond to all issues related to industrialization of space, and alleviate the work of businesses that are developing new technologies.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 256
- Round size: Seed $610k–$43M; Series A $2.5M–$71M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Cake.jp — Cake.jp operates "Cake.jp", a comprehensive cake delivery site.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Fabric Tokyo — FABRIC TOKYO is a Japanese startup provides a direct-to-consumer custom-made apparel brand. (former-company name Lifestyle Design Co., Ltd.). It enables customers to save their sizes, idea fabrics, and favorite designs, allowing them to make their original clothing later.FABRIC TOKYO was founded in 2012 by Yuichiro Mori and is based in Tokyo,Japan.
Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, Myanmar
Investor stats
- Total investments: 148
- Round size: Seed $933k–$30M; Series A $1.2M–$58M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $36M in 2020
Portfolio highlights
- Naorai — Naorai is a food and beverage firm that manufactures wine, beer, spirits, and non-alcoholic beverages.
- Dioseve — Dioseve is providing novel possibilities for all life.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Japan, Indonesia, United States
Investor stats
- Total investments: 83
- Round size: Seed $1M–$50M; Series A $1.2M–$46M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $691M in 2020
Portfolio highlights
- MW — MW is a smart home solution company that develops smart residential physical AI, robotics, and home design services.
- InsightX — InsightX is a technology platform focused on empowering businesses by simplifying complex processes and enabling smarter, more personalized user experiences.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 66
- Round size: Seed $1M–$61M; Series A $1.9M–$92M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- LEP —
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $15M–$425M; Corporate Round $1.3M–$1.7B
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord is a robotics company that combines hardware and software robotics via an integrated SaaS offering. Its focus is on smart robotics digitization, smart content management with AI, and helping enable RPA and business processes.Ripcord is based in Hayward, California, and is backed by leading investors Kleiner Perkins Caufield & Byers,Google Ventures, Lux Ventures, Legend Star, and Apple Co-Founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 295
- Round size: Seed $314k–$18M; Series A $2.7M–$91M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $2.4B in 2021
Portfolio highlights
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Black Cat Carnival Inc. is a communication service development company.
- Pixie Dust Technologies — Pixie Dust Technologies is a developer of computational technologies, including its ultrasonic phased array system with which one can generate force in mid-air; transport things in mid-air without touching anything; target and deliver different sounds from person to person in a crowd; direct guide-dogs; and even apply this in agricultural farming.
Delight Ventures is a venture capital firm that thoroughly reduces the hurdles of entrepreneurship in Japan and supports entrepreneurs in the world. Entrepreneurship is taken as a natural career path, and we aim to be a society where both successful and unsuccessful people can continue to take on challenges.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, South Korea
Investor stats
- Total investments: 84
- Round size: Seed $610k–$28M; Series A $3.3M–$156M; Series B $429k–$312M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Ababa — Ababa provides recruitment and employment solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
- Josh Collaboration — Josh Collaboration is a software company that provides mailing, fax transmission, and partner management services.
JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.
Show more...Investment focus
- Industry: Information Technology, Software, Medical
- Stage:Series B, Series C
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 103
- Round size: Series B $4.1M–$142M; Series C $4.3M–$354M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Grooves — grooves has been providing #1 Web applications for the recruiters as the web community to build to meet with each other for new business opportunities and possible partnerships in Japan since 2004. Now,there are more than 3,000 companies customers in Asiapacific.
- Turing — Turing develops and manufactures fully autonomous vehicles.
- Atom — Atom is a humanoid robot built platform. Its bipedal, dual-armed robots are designed not just as industrial tools but as collaborators that expand human capability. By combining advanced Physical AI—environmental perception, judgment, and action planning—with robust robotic hardware, Atom is creating adaptive agents capable of working acrossdiverse settings to augment or, where appropriate, replace human labor. The company positions these robots as a next step in societal evolution: a new class of machines that learn and behave in human-like ways to advance productivity, safety, and quality of life.
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, Japan, Canada
Investor stats
- Total investments: 24
- Round size: Seed $10M–$42M; Series A $6.6M–$25M; Series B $8.2M–$553M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $95M in 2019
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 72
- Round size: Seed $792k–$62M; Series A $2.8M–$25M; Series B $6.5M–$47M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Recerqa — Recerqa is a supply chain management SaaS that utilizes advanced development technology and AI to improve the purchasing, inventory, and sales management experiences.
- Mign — Mign offers a generative AI-related SaaS solutions for the construction and real estate fields.
- Henry — Henry develops and provides a cloud-based electronic medical record and receipt system for small and medium-sized hospitals.
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 434
- Round size: Series A $9.2M–$87M; Series B $15M–$112M; Series C $22M–$165M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Vestwell — Vestwell is a digital savings platform redefining the way workplace plans are powered today.
- Lemon Cash — Lemon Cash is digital wallet with FIAT and crypto capabilities. End to end digital ecosystem for Latin America.
- Checkmate Pharmaceuticals — Empowering the immune system to beat back cancer
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Show more...Investment focus
- Industry: Medical, Software, Therapeutics
- Stage:Series A, Seed, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.6M–$2.7M; Series A $690k–$51M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Neumo — Neumo is a musical education-based firm that offers pitch measurement courses, programs, consulting, and tests.
- RevolKa — RevolKa manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
- Neros Technologies — Neros is vertically integrating production of unmanned defense systems in the United States, securing the autonomous supply chain. Are you with us?
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Corporate Round
- Geography: United States, Japan, China
Investor stats
- Total investments: 61
- Round size: Grant $5k–$8.7M; Corporate Round $52M–$1.4B
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- BaseLaunch — We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures, developing cutting-edge therapeutics.
- Beacon Biosignals — AI + EEG to change the way patients are treated for disorders of the brain.
- Innovent Biologics — Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
- THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
- Mira Robotics — Mira Robotics is a software based company provide services that can robots in various fields.
SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Series A
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 78
- Round size: Series A $11M–$241M; Series B $25M–$425M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $2.1B in 2018
Portfolio highlights
- Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
- Alloyed — Alloyed delivers cutting-edge innovation in materials science, additive manufacturing, and advanced metallurgy. Explore our technologies and career opportunities.
- UnaBiz — Based in Singapore, Taiwan and Japan, UnaBiz delivers end-to-end customised IoT solutions worldwide. Simple, cost-efficient & low maintenance
Daiwa Corporate Investment is a private investment firm of Daiwa Securities Group that has been engaged in overseas VC investments by taking advantage of an extensive business network in Japan and foreign countries, long experience and professional knowledge, and by supporting the growth of a number of overseas portfolio companies and their stockexchange listings.
Show more...Investment focus
- Industry: Software, Task Management, Internet
- Stage:Series A, Seed
- Geography: Japan, United States, France
Investor stats
- Total investments: 133
- Round size: Seed $4.3M–$14M; Series A $4.5M–$71M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $1.5B in 2018
Portfolio highlights
- NovAccel — NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes.
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 120
- Round size: Seed $1.8M–$9.3M; Series A $1.8M–$20M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
- Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
Green Core is an investment firm.
Show more...Investment focus
- Industry: Pharmaceutical, Health Care, Medical
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 8
- Round size: Series A $2M–$4.8M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- JiMED — JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication.
- Cosomil — Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies.
- Physiologas Technologies — Physiologas Technologies is a manufacturing company that designs and develops medical equipment for the healthcare industry.
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 146
- Round size: Seed $1M–$3.1M; Series A $3M–$76M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Phamily — Full-service care transformation powered by 10+ years of experience, a dedicated clinical workforce, and our AI-enabled platform.
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 16
- Round size: Seed $1.5M–$2M; Series A $955k–$128M; Series B $5.1M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nexta — Nexta manufactures site, issues such as analog management, personalization of operations & labor shortages are becoming more serious.
- OOYOO — OOYOO Co., Ltd. is a DeepTech venture that combines international entrepreneurial spirit, and a 'Made In Japan' excellence, to bring the latest innovations in clean technology to society for a smarter, cleaner, and more mobile world.
- Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1820
- Round size: Seed $186k–$4.6M; Pre-Seed $108k–$750k; Series A $4.6M–$28M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Agentio — Agentio's patent-pending ad platform empowers marketers to finally unlock scalable, creator-led advertising. Programmatically buy the highest quality creator and influencer ad reads to deliver unprecedented efficiency and performance.
- Codis.io — COD LEGAL BLOG CONTACT US Areas We Serve California Florida TEXAS Ohio Trusted Insights on Birth Injury and Medical Negligence Law COD LEGAL BLOG is a dedicated legal information platform created to help readers understand complex legal matters in a clear and structured way. Click here to learn more. The legal system can often feel
- Quantflo — Options market intelligence and structured trade planning for Indian markets.
WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Seed, Series A, Convertible Note
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $1.2M–$38M; Series A $1.3M–$14M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
- Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Medical, Health Care, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 13
- Round size: Seed $403k–$17M; Series A $15M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AMI — AMI Corp is engaged in medical consulting, medical device development and writing.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
- HEAL-lll — HEAL-lll is a multifaceted firm that merges healthcare, technology, and gamification to promote individual and organizational well-being.
Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.
Show more...Investment focus
- Industry: Manufacturing, Task Management, Medical
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 30
- Round size: Seed $515k–$61M; Series A $6.1M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TSK Corporation —
- IKOU — IKOU is an inclusive brand for babies and children that creates products valued by all users. The company's featured products include portable seats, bibs, and children's clothing products along with online services.
- Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
Higegin Capital is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 25
- Round size: Series A $1.2M–$75M; Series B $3.8M–$14M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $137M in 2020
Portfolio highlights
- Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
- EUV Photon — EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 7
- Round size: Series A $3M–$106M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States, China, India
Investor stats
- Total investments: 365
- Round size: Series A $6.4M–$62M; Series B $8.5M–$80M; Series C $14M–$115M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- GoodData.AI — GoodData is a leading composable data and analytics platform. Build, embed, and scale analytics on demand, with zero vendor lock-in.
- Fuse Universal — Fuse is the learning platform that allows your people to connect with the knowledge and expertise they need to improve their skills and perform.
- Lighthouse — Lighthouse transforms complexity into confidence with actionable insights, business intelligence & pricing solutions that maximize revenue.
QB Capital is make equity investments in venture companies.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Seed, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 54
- Round size: Seed $641k–$43M; Series A $1.3M–$213M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $429M in 2015
Portfolio highlights
- Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
- Equmenopolis — Equmenopolis is an information services company that specializes in conversational AI agent platforms and application developments.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Energy & Environment Investment, Inc. (EEI) is Japan’s first venture capital specialized in the clean technology sector. With core members who have rich hands on experience in founding and managing venture companies, we aim to provide risk money and various strategic values to promising venture companies and businesses.
Show more...Investment focus
- Industry: Energy, Internet of Things, Software
- Stage:Series A, Series B
- Geography: Japan, United States, Canada
Investor stats
- Total investments: 123
- Round size: Series A $2M–$105M; Series B $3.7M–$553M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $147M in 2019
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- Hacobell — Hacobell is a logistics company that offers services in freight servicing, dispatch, and delivery.
- Power Wave — Power Wave seeks a carbon-neutral world using wave technology for wireless power, tackling global warming and fuel depletion.
Chugin Capital Partner is a venture capital firm that invests in startups and business succession.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 26
- Round size: Seed $760k–$7.1M; Series A $1.2M–$3.7M; Series B $5.9M–$54M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- KG Motors — KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
- Pixie Dust Technologies — Pixie Dust Technologies is a developer of computational technologies, including its ultrasonic phased array system with which one can generate force in mid-air; transport things in mid-air without touching anything; target and deliver different sounds from person to person in a crowd; direct guide-dogs; and even apply this in agricultural farming.
Koki Yabu is Founder, President & CEO at Mobcast inc.
Show more...Investment focus
- Industry: Content, Finance, Data Mining
- Stage:Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Mobcast group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
- SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
Biotechnology Investor funding in Japan at a glance
Stats across 414 deals from 501 investors.
Access all 501 investors in Japan Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 501 investors investing in Japan Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!